FDA Approves Biannual HIV Prevention Shot: Key Facts
TL;DR
A new twice-yearly HIV prevention shot called Yeztugo has been approved by the FDA, offering a potentially more effective and easier alternative to daily pills for at-risk individuals, though concerns about cost and accessibility remain.
- Here’s what everyone should know about this new HIV prevention shot The Washington Post
- FDA approves powerful HIV prevention drug: What to know about Yeztugo NBC News
- Regulators Approve a Twice-Yearly Shot to Prevent H.I.V. Infection The New York Times
- FDA approves twice-a-year injection for HIV prevention CNN
- An Open Letter from Daniel O’Day, Chairman & CEO Gilead Sciences
Want the full story? Read the original reporting
Read on The Washington Post